OEM Supply Amble Tirzepatide Peptide 4731.33 MW - Clinical Research Compound

Amble Tirzepatide (LY3437943) is a novel peptide compound with triple receptor agonist activity, targeting GLP-1, GIP, and glucagon receptors simultaneously. This unique mechanism makes amble tirzepatide particularly effective for metabolic research applications including weight management and glucose control studies.

The amble tirzepatide compound demonstrates exceptional purity (≥99% by HPLC) and stability when stored under proper conditions (2-8°C). Our manufacturing process ensures batch-to-batch consistency for reliable research results.

As a leading supplier, we offer flexible packaging options from small vials (5mg/10mg) to bulk quantities (1kg) to meet various research requirements. All amble tirzepatide products are strictly for laboratory research use only.

Key pharmacological characteristics of amble tirzepatide include:
- Triple receptor agonist activity
- Molecular weight: 4731.33
- White lyophilized powder form
- Excellent stability profile
- High binding affinity

Our amble tirzepatide production follows strict GMP guidelines with comprehensive quality control including HPLC purity testing, mass spectrometry verification, and endotoxin testing. Researchers can request certificates of analysis for each batch.

The compound's unique sequence (H-Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2) contributes to its exceptional receptor binding properties and metabolic effects.

For research institutions requiring custom formulations or specific packaging of amble tirzepatide, our technical team can develop tailored solutions to meet specialized study protocols.